Jul 25 |
Why AstraZeneca's CEO isn't worried about costs
|
Jul 25 |
Sanofi (SNY) Q2 Earnings Beat, Sales Miss, 2024 View Raised
|
Jul 25 |
Astrazeneca (AZN) Reports Q2 Earnings: What Key Metrics Have to Say
|
Jul 25 |
NHS spending rules risk depriving Britain of new medicine, warns AstraZeneca boss
|
Jul 25 |
AstraZeneca Slides Despite Beating Quarterly Expectations And Hiking Its Outlook
|
Jul 25 |
AstraZeneca Posts Mixed Q2 Earnings, Still Raises Annual Guidance On Strong Demand For Cancer, Rare Disease Medicines
|
Jul 25 |
AstraZeneca (AZN) Beats on Q2 Earnings & Sales, Ups '24 View
|
Jul 25 |
AstraZeneca Posts Earnings Beat, Lifts Guidance on Strong Sales
|
Jul 25 |
Sanofi Raises 2024 Profit Outlook On Strong Q2 Earnings, Blockbuster Drug Dupixent Sees Strong Demand
|
Jul 25 |
AstraZeneca slips despite 2024 guidance raise on medicines demand
|